POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS

Detalles Bibliográficos
Autores principales: Selvanathan, D., parthasarathy, R., Rohit, A., Venkatramanan, S., Dsouza, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475093/
http://dx.doi.org/10.1016/j.ekir.2022.07.020
_version_ 1784789830510575616
author Selvanathan, D.
parthasarathy, R.
Rohit, A.
Venkatramanan, S.
Dsouza, C.
author_facet Selvanathan, D.
parthasarathy, R.
Rohit, A.
Venkatramanan, S.
Dsouza, C.
author_sort Selvanathan, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9475093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-94750932022-09-15 POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS Selvanathan, D. parthasarathy, R. Rohit, A. Venkatramanan, S. Dsouza, C. Kidney Int Rep Article Published by Elsevier Inc. 2022-09 2022-09-15 /pmc/articles/PMC9475093/ http://dx.doi.org/10.1016/j.ekir.2022.07.020 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Selvanathan, D.
parthasarathy, R.
Rohit, A.
Venkatramanan, S.
Dsouza, C.
POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
title POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
title_full POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
title_fullStr POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
title_full_unstemmed POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
title_short POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
title_sort pos-005 neutralizing anti sars-cov-2 antibody response to covid - 19 vaccines: chadox1-ncov-19 and bbv152 among haemodialysis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475093/
http://dx.doi.org/10.1016/j.ekir.2022.07.020
work_keys_str_mv AT selvanathand pos005neutralizingantisarscov2antibodyresponsetocovid19vaccineschadox1ncov19andbbv152amonghaemodialysispatients
AT parthasarathyr pos005neutralizingantisarscov2antibodyresponsetocovid19vaccineschadox1ncov19andbbv152amonghaemodialysispatients
AT rohita pos005neutralizingantisarscov2antibodyresponsetocovid19vaccineschadox1ncov19andbbv152amonghaemodialysispatients
AT venkatramanans pos005neutralizingantisarscov2antibodyresponsetocovid19vaccineschadox1ncov19andbbv152amonghaemodialysispatients
AT dsouzac pos005neutralizingantisarscov2antibodyresponsetocovid19vaccineschadox1ncov19andbbv152amonghaemodialysispatients

Ejemplares similares